(Q47838110)

6 February 2018

title

Levels of apolipoprotein A-II in cerebrospinal fluid in patients with neuroborreliosis are associated with lipophagocytosis. (English)

1 reference

6 February 2018

0 references

0 references

1 reference

L Táborský

1

1 reference

6 February 2018

P Adam

2

1 reference

6 February 2018

O Sobek

3

1 reference

6 February 2018

M Dostál

4

1 reference

6 February 2018

J Dvoráková

5

1 reference

6 February 2018

L Dubská

6

1 reference

6 February 2018

publication date

1 January 2003

1 reference

6 February 2018

published in

Folia Microbiologica

1 reference

6 February 2018

volume

48

1 reference

6 February 2018

issue

6

1 reference

6 February 2018

page(s)

849-855

1 reference

6 February 2018

https://scigraph.springernature.com/pub.10.1007/bf02931523

exact match

0 references

cites work

Marked increases in concentrations of apolipoprotein in the cerebrospinal fluid of poliovirus-infected macaques: relations between apolipoprotein concentrations and severity of brain injury

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02931523

Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02931523

Apo A-I and apo E concentrations in cerebrospinal fluids of patients with acute meningitis.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02931523

Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis

21 January 2018

1 reference

12 December 2020

Apolipoprotein A-II gene and development of amyloidosis and senescence in a congenic strain of mice carrying amyloidogenic ApoA-II

1 reference

12 December 2020

Lipoproteins in the central nervous system

1 reference

12 December 2020

Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.

1 reference

12 December 2020

Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases.

1 reference

12 December 2020

Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes

1 reference

12 December 2020

Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin

1 reference

12 December 2020

Apolipoprotein E and multiple sclerosis: a biochemical and genetic investigation

1 reference

12 December 2020

Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid

1 reference

12 December 2020

Optic nerve regeneration in adult fish and apolipoprotein A-I

1 reference

12 December 2020

High-density lipoprotein and cerebral endothelial cells in vitro: interactions and transport

1 reference

12 December 2020

A sensitive time-resolved immunofluorometric assay for the measurement of apolipoprotein B in cerebrospinal fluid. Application to multiple sclerosis and other neurological diseases

1 reference

12 December 2020

Expression of apolipoprotein A-I in porcine brain endothelium in vitro.

1 reference

12 December 2020

Induction of rat E and chicken A-I apolipoproteins and mRNAs during optic nerve degeneration.

1 reference

12 December 2020

Pathogenesis of neuroborreliosis--lessons from a monkey model

1 reference

12 December 2020

1 reference

12 December 2020

Cerebrospinal fluid lipoproteins in Alzheimer's disease

1 reference

12 December 2020

Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs

1 reference

12 December 2020

ApoA-II versus ApoA-I: two for one is not always a good deal.

1 reference

12 December 2020

Cytologic features of cerebrospinal fluid in Lyme disease

1 reference

12 December 2020

[Tau protein in cerebrospinal fluid--a potential marker of Alzheimer's disease].

1 reference

12 December 2020

Apolipoproteins in human cerebrospinal fluid

1 reference

12 December 2020

Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy controls.

1 reference

12 December 2020

Characterization of four lipoprotein classes in human cerebrospinal fluid

1 reference

12 December 2020

Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain.

1 reference

12 December 2020

Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients

1 reference

12 December 2020

Apolipoproteins in rat cerebrospinal fluid: A comparison with plasma lipoprotein metabolism and effect of aging

1 reference

12 December 2020

A proteomic approach identifies proteins in hepatocytes that bind nascent apolipoprotein B.

1 reference

12 December 2020

Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet

1 reference

12 December 2020

The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B.

1 reference

12 December 2020

Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation

1 reference

12 December 2020

Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02931523

1 reference

6 February 2018

release_bduptid7ifgflmrcm3qeedk3na

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bduptid7ifgflmrcm3qeedk3na

24 November 2022

mapped directly with Wikidata item

PubMed ID

15058201

1 reference

6 February 2018